S.Y. Amy Cheung
Publications by Year
Research Areas
Pulsars and Gravitational Waves Research, PI3K/AKT/mTOR signaling in cancer, Advanced Breast Cancer Therapies, Cosmology and Gravitation Theories, PARP inhibition in cancer therapy
Most-Cited Works
- → A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA -Mutated Breast and Gynecologic Cancers(2017)143 cited
- → BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population(2019)84 cited
- → Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children(2017)75 cited
- → Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis(2021)53 cited
- → Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)(2019)40 cited
- → Abstract CT026: Phase I study of AZD6738, an inhibitor of ataxia telangiectasia Rad3-related (ATR), in combination with olaparib or durvalumab in patients (pts) with advanced solid cancers(2018)34 cited
- → Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study(2024)26 cited
- → Exploration of the intercellular heterogeneity of topotecan uptake into human breast cancer cells through compartmental modelling(2008)21 cited
- → Whole body physiologically based modelling of β‐blockers in the rat: events in tissues and plasma following an i.v. bolus dose(2017)13 cited
- → Characterization of the disposition of fostamatinib in Japanese subjects including pharmacokinetic assessment in dry blood spots: results from two phase I clinical studies(2015)10 cited